SCOPUS 정보 검색 플랫폼

Statistics in Biosciences

Volumn 4, Issue 2, 2012, Pages 235-244

Combined Estimation of Treatment Effects Under a Discrete Random Effects Model

(2) Lan, K K Gordon a Pinheiro, José a

a JOHNSON AND JOHNSON (United States)

Author keywords

Clinical trials; Combination of information; Evidence synthesis; Meta analysis; Multi regional trials

Indexed keywords

ARTICLE; CALCULATION; CLINICAL STUDY; DATA ANALYSIS; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RANDOMIZATION; THERAPY EFFECT; TREATMENT RESPONSE;

EID: 84870394059 PISSN: 18671764 EISSN: 18671772 Source Type: Journal
DOI: 10.1007/s12561-012-9054-9 Document Type: Article

Times cited : (19)

References (9)

1
- 84889351499
- Chichester: Wiley
- Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009) Introduction to meta-analysis. Wiley, Chichester.
- (2009) Introduction to Meta-Analysis
- Borenstein, M.¹ Hedges, L.V.² Higgins, J.P.T.³ Rothstein, H.R.⁴

2
- 0022992740
- Meta-analysis in clinical trials
- DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
- (1986) Control Clin Trials , vol.7 , pp. 177-188
- DerSimonian, R.¹ Laird, N.²

3
- 0032886748
- Valid inference in random effects meta-analysis
- Follmann DA, Proschan MA (1999) Valid inference in random effects meta-analysis. Biometrics 55: 732-737.
- (1999) Biometrics , vol.55 , pp. 732-737
- Follmann, D.A.¹ Proschan, M.A.²

4
- 77957340034
- Consideration of regional difference in design and analysis of multi-regional trials
- Hung HMJ, Wang SJ, O'Neill RT (2010) Consideration of regional difference in design and analysis of multi-regional trials. Pharm Stat 9: 173-178.
- (2010) Pharm Stat , vol.9 , pp. 173-178
- Hung, H.M.J.¹ Wang, S.J.² O'Neill, R.T.³

5
- 9944262983
- Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
- doi:10.1016/S0140-6736(04)17514-4
- Jüni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M (2004) Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 364(9450): 2021-2029. doi: 10. 1016/S0140-6736(04)17514-4.
- (2004) Lancet , vol.364 , Issue.9450 , pp. 2021-2029
- Jüni, P.¹ Nartey, L.² Reichenbach, S.³ Sterchi, R.⁴ Dieppe, P.A.⁵ Egger, M.⁶

6
- 0035934070
- Risk of cardiovascular events associated with selective COX-2 inhibitors
- PMID 11509060, doi:10.1001/jama.286.8.954
- Mukherjee D, Nissen SE, Topol EJ (2001) Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286(8): 954-959. doi: 10. 1001/jama. 286. 8. 954. PMID 11509060.
- (2001) Jama , vol.286 , Issue.8 , pp. 954-959
- Mukherjee, D.¹ Nissen, S.E.² Topol, E.J.³

7
- 34250212715
- Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
- PMID 17517853, doi:10.1056/NEJMoa072761
- Nissen SE, Wolski K (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356(24): 2457-2471. doi: 10. 1056/NEJMoa072761. PMID 17517853.
- (2007) N Engl J Med , vol.356 , Issue.24 , pp. 2457-2471
- Nissen, S.E.¹ Wolski, K.²

8
- 78650217349
- Assessment of consistency of treatment effects in multiregional clinical trials
- Quan H, Li M, Chen J, Gallo P, Binkowitz B, Ibia E, Tanaka Y, Ouyang P, Luo X, Li G (2010) Assessment of consistency of treatment effects in multiregional clinical trials. Drug Inf J 44: 617-632.
- (2010) Drug Inf J , vol.44 , pp. 617-632
- Quan, H.¹ Li, M.² Chen, J.³ Gallo, P.⁴ Binkowitz, B.⁵ Ibia, E.⁶ Tanaka, Y.⁷ Ouyang, P.⁸ Luo, X.⁹ Li, G.¹⁰

9
- 0013369397
- Chichester: Wiley
- Whitehead A (2002) Meta-analysis of controlled clinical trials. Wiley, Chichester.
- (2002) Meta-Analysis of Controlled Clinical Trials
- Whitehead, A.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.